MedTrace Logo

Postoperative Analgesia in Thoracic Surgery

NCT07694141 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2026-07-20

No results posted yet for this study

Summary

Analgesic management in thoracic surgery presents a particular challenge for the anesthesiologist, given the intensity of postoperative pain associated with thoracotomy, a surgical procedure that can impact respiratory function and the patient's subsequent recovery. Epidural analgesia is the gold standard. When epidural catheter placement is not feasible, erector spinae plane block is a safe alternative. The ultrasound target is easily visualized, and the injection site is far from the neuraxis, pleura, and major vascular structures. Consequently, this block has been incorporated into standard clinical practice as a treatment option for patients with complex cases or as an alternative approach when epidural catheter placement is not feasible. The primary objective of this study is to assess the effectiveness of postoperative analgesia in patients undergoing elective thoracic surgery.

Study Population Design A prospective observational follow-up study will be conducted. ASA I-III patients undergoing scheduled thoracic surgery between November 1 and December 31, 2025, will be included. Their analgesic management will be based on standard clinical practice.

Conditions

  • Postoperative Pain Management

Interventions

DIAGNOSTIC_TEST

Postoperative pain through Visual analogue scale

Postoperative pain will be assessed using the visual analog pain scale at 1, 3, 6, 24, and 48 hours postoperatively.

DIAGNOSTIC_TEST

Postoperative complications

The patient's postoperative evolution will be assessed until hospital discharge, in order to define the appearance of postoperative complications classified according to Clavien-Dindo classification.

Sponsors & Collaborators

  • Hospital Universitario de Gran Canaria Doctor Negrín

    lead OTHER

Principal Investigators

  • Ángel Becerra, MD PhD · Hospital Universitario de Gran Canaria Doctor Negrín

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-15
Primary Completion
2026-12-31
Completion
2027-01-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07694141 on ClinicalTrials.gov